BeiGene Ownership | Who Owns BeiGene?


OverviewForecastRevenueFinancialsChart

BeiGene Ownership Summary


BeiGene is owned by 43.88% institutional investors, 17.79% insiders, and 38.33% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 7.80% of BGNE shares. American Funds New Perspective A is the top mutual fund, with 2.64% of its assets in BeiGene shares.

BGNE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBeiGene43.88%17.79%38.33%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp10.57M7.80%$1.51B
Capital investors7.01M5.17%$1.00B
Hhlr advisors5.18M3.82%$738.59M
Primecap management co/ca/4.99M3.68%$711.39M
Baillie gifford3.68M2.72%$525.30M
Temasek (private)3.01M2.22%$430.03M
Price t rowe associates inc /md/2.27M1.68%$324.26M
Fmr1.65M1.22%$235.00M
Blackrock959.19K0.71%$136.85M
Capital, inc./ca/855.13K0.63%$122.00M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Baker bros. advisors lp10.57M19.27%$1.51B
Hhlr advisors5.18M18.22%$738.59M
Long corridor asset management52.62K7.11%$7.51M
Exome asset management33.20K4.22%$4.74M
Boxer capital500.00K3.76%$71.33M
Nan fung group23.02K3.50%$3.28M
Temasek (private)3.01M2.00%$430.03M
Jgp global gestao de recursos ltda.10.46K1.90%$1.49M
Affinity asset advisors110.00K1.81%$15.69M
Soleus capital management137.70K1.73%$19.65M

Top Buyers

HolderShares% AssetsChange
Point72 asset management381.38K0.14%381.38K
Price t rowe associates inc /md/2.27M0.04%246.73K
Artisan partners limited partnership208.42K0.04%63.49K
Woodline partners lp45.08K0.06%45.08K
Long corridor asset management52.62K7.11%42.58K

Top Sellers

HolderShares% AssetsChange
Vestal point capital, lp---350.00K
Artal group303.37K1.10%-101.41K
Invesco111.31K0.00%-94.85K
Bank of america corp /de/287.35K0.00%-65.75K
Pictet asset management sa108.83K0.02%-55.49K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management381.38K0.14%381.38K$54.41M
Woodline partners lp45.08K0.06%45.08K$6.43M
Citigroup15.00K0.00%15.00K$2.14M
Susquehanna group, llp11.09K0.00%11.09K$1.58M
Driehaus capital management8.19K0.01%8.19K$1.17M

Sold Out

HolderChange
Financial gravity asset management-1.00
Allworth financial lp-1.00
Advisornet financial-2.00
Concourse financial group securities-3.00
Mather group, llc.-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202423414.15%46,472,316-0.63%433.69%10717.58%8427.27%
Jun 30, 2024203-1.93%46,765,6100.79%341.75%90-29.69%6541.30%
Mar 31, 2024207-0.96%46,399,4933.32%444.08%12837.63%46-37.84%
Dec 31, 20232091.95%44,906,761-4.78%331.62%935.68%747.25%
Sep 30, 2023205-3.76%47,161,4730.33%452.21%88-2.22%69-2.82%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds New Perspective A2.80M2.64%-
Capital Group New Perspective Comp2.80M2.64%-
Vanguard PRIMECAP Inv2.20M2.07%-80.00K
Capital Group New Geography Equity Comp1.16M1.09%-693.60K
American Funds New World A1.16M1.09%-
Vanguard Capital Opportunity Inv1.08M1.02%51.00K
T. Rowe Price Health Sciences748.31K0.70%47.09K
PRIMECAP Odyssey Aggressive Growth704.96K0.66%-
PRIMECAP Odyssey Growth683.73K0.64%2.30K
Fidelity Growth Compy Commingled Pl S652.27K0.61%3.74K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 10, 2024Wang Xiaodong Chair, Scientific Advisory BrdSell$1.85M
Dec 10, 2024Wang Xiaodong Chair, Scientific Advisory BrdSell$1.73M
Dec 10, 2024Wang Xiaodong Chair, Scientific Advisory BrdSell$477.37K
Dec 10, 2024Wang Xiaodong Chair, Scientific Advisory BrdSell$1.31M
Dec 10, 2024Wang Xiaodong Chair, Scientific Advisory BrdSell$1.19M

Insider Transactions Trends


DateBuySell
2024 Q4-47
2024 Q3-12
2024 Q2-38
2024 Q1-15
2023 Q4-2

BGNE Ownership FAQ


Who Owns BeiGene?

BeiGene shareholders are primarily institutional investors at 43.88%, followed by 17.79% insiders and 38.33% retail investors. The average institutional ownership in BeiGene's industry, Biotech Stocks , is 47.04%, which BeiGene falls below.

Who owns the most shares of BeiGene?

BeiGene’s largest shareholders are Baker bros. advisors lp (10.57M shares, 7.80%), Capital investors (7.01M shares, 5.17%), and Hhlr advisors (5.18M shares, 3.82%). Together, they hold 16.79% of BeiGene’s total shares outstanding.

Does Blackrock own BeiGene?

Yes, BlackRock owns 0.71% of BeiGene, totaling 959.19K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 136.85M$. In the last quarter, BlackRock increased its holdings by 10.52K shares, a 1.11% change.

Who is BeiGene’s biggest shareholder by percentage of total assets invested?

Baker bros. advisors lp is BeiGene’s biggest shareholder by percentage of total assets invested, with 19.27% of its assets in 10.57M BeiGene shares, valued at 1.51B$.

Who is the top mutual fund holder of BeiGene shares?

American Funds New Perspective A is the top mutual fund holder of BeiGene shares, with 2.64% of its total shares outstanding invested in 2.8M BeiGene shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools